Skip to main content
Clinical Trials/NCT01196312
NCT01196312
Completed
Not Applicable

Novel Intervention for Drug Use and HIV Risk Among Anxiety Sensitive Heroin Users

University of Maryland, College Park1 site in 1 country60 target enrollmentOctober 2009
ConditionsAnxiety

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anxiety
Sponsor
University of Maryland, College Park
Enrollment
60
Locations
1
Primary Endpoint
Anxiety Sensitivity Index-3
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and above levels of anxiety sensitivity that will involve the testing of a specialized protocol for improving treatment retention and outcomes for heroin dependent individuals in a residential substance use treatment. ASTH-HR will integrate established treatment modules such as Healthy Relationships, along with interoceptive exposure, affect management, and psycho-education exercises developed for anxiety prevention and treatment programs with standard substance use treatment.

Registry
clinicaltrials.gov
Start Date
October 2009
End Date
September 2011
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Joe Smith

Director - HRPP (C. Lejuez is no longer at UMD)

University of Maryland, College Park

Eligibility Criteria

Inclusion Criteria

  • exhibit a score of 21 on a self-report measure of anxiety sensitivity
  • be in 28 days of residential substance use treatment.
  • meet criteria for current opioid dependence as determined by SCID interview administered at intake.

Exclusion Criteria

  • evidence of limited mental competency
  • the inability to give informed, voluntary, written consent to participate
  • current psychosis
  • current bipolar disorder.

Outcomes

Primary Outcomes

Anxiety Sensitivity Index-3

Time Frame: 24 weeks

Secondary Outcomes

  • Timeline Follow Back 90 days(24 weeks)

Study Sites (1)

Loading locations...

Similar Trials